107 filings
Page 4 of 6
8-K
rw5uavhh8c30jgkw
19 Jul 21
Departure of Directors or Certain Officers
4:53pm
8-K
y6tn211ked4 2zb8
22 Jun 21
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
2gzeq9i8hltlblhco
12 May 21
Regulation FD Disclosure
9:01am
8-K
pqbmh873qdp 092jc
11 May 21
Prelude Therapeutics Announces First Quarter 2021 Financial Results and Operations Update
8:00am
DEFA14A
gxwsce4ly8d2as
29 Apr 21
Additional proxy soliciting materials
4:09pm
DEF 14A
q3o5nc95ou2 77ju1sbu
29 Apr 21
Definitive proxy
4:05pm
8-K
39q iuuxlz14i3
17 Mar 21
Regulation FD Disclosure
9:02am
S-8
o4hm5o en
16 Mar 21
Registration of securities for employees
4:31pm
10-K
0w3g99qywvwb27kg9
16 Mar 21
Annual report
8:20am
8-K
q4fzup4merf cxfyzgk
16 Mar 21
Prelude Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Operational Update
8:10am
8-K
85uivz02phfyylqt nyf
8 Mar 21
Departure of Directors or Certain Officers
4:09pm
8-K
x99ue u9jw607hhv3
28 Jan 21
Departure of Directors or Certain Officers
4:46pm
424B4
ik6axuyzy
7 Jan 21
Prospectus supplement with pricing info
4:11pm
EFFECT
b3q961 mfho9
7 Jan 21
Notice of effectiveness
12:15am
S-1MEF
zn2kep1e0qitds3box2z
6 Jan 21
Registration of additional securities for an S-1
8:48pm
8-K
adeura 8zk0huuj
4 Jan 21
Results of Operations and Financial Condition
4:19pm
CORRESP
zz574sq5neetso3x
4 Jan 21
Correspondence with SEC
12:00am
CORRESP
4fbxdqyz luczwuo
4 Jan 21
Correspondence with SEC
12:00am